News
Pharmaprogress’ real-life cases in AEFI symposium Round Table on Nitrosamines
Pharmaprogress’ real-life cases in AEFI symposium Round Table on Nitrosamines Luca Gramaccioni, Site General Manger at Kymos Pharmaprogress, was a guest speaker at the 40th AEFI symposium last May 11th. He presented “Nitrosamines: How (...) Read more
Your Stability Studies in Safe Hands
In recent years Kymos has experienced a surge in demand from drug manufacturers in need of a reliable outsourcing partner for their stability programmes. Kymos responded by making a major investment to build new (...) Read more
The revolution in COVID vaccine development
The new COVID-19 vaccine developed by Pfizer/BioNTech was approved by the EMA last December and now Moderna’s is following suit. Both are based on mRNA technology and represent a very different type of vaccine (...) Read more
Batch Testing and Release: Life after Brexit
We at KYMOS and ASPHALION are long-time partners in providing analytical and regulatory services to international pharma and biotech sectors. Our testimony goes beyond the conventional “CRO trading with UK clients” to overcome internalization (...) Read more
